WE SPECIALISE IN MARKET ACCESS IN ASIA PACIFIC AND EMERGING MARKETS

Between our in-house consultants and network of market specialists and on-the-ground experts, everyone that works on your project team will bring local market expertise and experience of the access environment. This ensures we can direct you to the optimal access pathway for your product, which in Asia Pacific and emerging markets, is not always obvious. It also ensures we know what you need to do to successfully navigate that pathway in the shortest possible time.
 

WE SUPPORT ACCESS IMPLEMENTATION, AS WELL AS PROVIDING STRATEGIC GUIDANCE

Achieving your desired business impact for a drug or device in Asia Pacific, Latin America and other emerging markets requires an innovative approach to market access, as well as effective implementation. We can help with both, devising the right access and commercial strategy and supporting local teams in their execution, ensuring that your access-related goals are met.

​

WE DELIVER ACCESS INSIGHTS THAT ARE CREDIBLE, MEANINGFUL AND ACTIONABLE

This requires speaking with the right stakeholders, which is why we personally manage a network of stakeholders from across the pharma and device value-chains in more than 25 markets in Asia Pacific and emerging markets. Our understanding of the markets also ensures we ask the right questions and, by conducting all stakeholder discussions ourselves, we ensure every one you commission us to do is a high-grade interaction that generates the insights you need. This is how we ensure our insights will help you make better informed access decisions in Asia Pacific and emerging markets.

​

WE CAN HELP YOU MAXIMISE PRIVATE, AS WELL AS REIMBURSEMENT, OPPORTUNITIES 

We can do more than just help you navigate the shifting requirements of the HTA environments of Asia Pacific and emerging markets.  We can help you develop and execute the right strategy for achieving commercial success in the private sector too. This may be  through traditional private health insurance, innovative "wellness plans", corporate clinic providers or, of course, patient self-pay programmes.

Selecting the right patient-pay model, and executing it effectively, depends on the brand, your reimbursement objectives and timelines and local market conditions. The traditional "Buy Some, Get Some Free" model, may not be the best option. Whether its payment-by-instalment, provider collaborations or some other approach, we have the experience to design the right programme and guide you to effective implementation.